DK0784973T3 - Quinoxalinderivater til behandling af tinnitus - Google Patents

Quinoxalinderivater til behandling af tinnitus

Info

Publication number
DK0784973T3
DK0784973T3 DK96306764T DK96306764T DK0784973T3 DK 0784973 T3 DK0784973 T3 DK 0784973T3 DK 96306764 T DK96306764 T DK 96306764T DK 96306764 T DK96306764 T DK 96306764T DK 0784973 T3 DK0784973 T3 DK 0784973T3
Authority
DK
Denmark
Prior art keywords
tinnitus
treatment
quinoxaline derivatives
medicament
chem
Prior art date
Application number
DK96306764T
Other languages
English (en)
Inventor
Steven Bradley Sands
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of DK0784973T3 publication Critical patent/DK0784973T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK96306764T 1995-10-10 1996-09-18 Quinoxalinderivater til behandling af tinnitus DK0784973T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US521795P 1995-10-10 1995-10-10

Publications (1)

Publication Number Publication Date
DK0784973T3 true DK0784973T3 (da) 2002-03-18

Family

ID=21714768

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96306764T DK0784973T3 (da) 1995-10-10 1996-09-18 Quinoxalinderivater til behandling af tinnitus

Country Status (10)

Country Link
US (1) US5840723A (da)
EP (1) EP0784973B1 (da)
JP (1) JPH09132530A (da)
AT (1) ATE212842T1 (da)
CA (1) CA2187402C (da)
DE (1) DE69619088T2 (da)
DK (1) DK0784973T3 (da)
ES (1) ES2168119T3 (da)
MX (1) MX9604692A (da)
PT (1) PT784973E (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9821179D0 (en) * 1998-09-30 1998-11-25 Merck Sharp & Dohme Therapeutic use
FR2787028B1 (fr) * 1998-12-15 2002-10-18 Aventis Pharma Sa Utilisation du riluzole dans le traitement des traumatismes acoustiques
US6362227B1 (en) 1999-03-02 2002-03-26 Sepracor, Inc. Methods for the treatment of tinnitus and other disorders using R(−)ketoptofen
US6436449B2 (en) 2000-03-02 2002-08-20 Bo Gidlund Use of a composition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0542689B1 (en) * 1991-11-15 1998-09-23 Phafag Aktiengesellschaft Use of 1-(aminoalkyl)-3-quinoxaline-2-on derivatives for the preparation of neuroprotective compositions
ES2123546T3 (es) * 1991-11-15 1999-01-16 Phafag Ag Uso de derivados de 1-(aminoalquil)-3-quinoxalina-2-ona para la preparacion de composiciones neuroprotectoras.
GB9419318D0 (en) * 1994-09-24 1994-11-09 Pfizer Ltd Therapeutic agents

Also Published As

Publication number Publication date
MX9604692A (es) 1998-04-30
EP0784973A3 (en) 1999-12-15
ATE212842T1 (de) 2002-02-15
PT784973E (pt) 2002-06-28
CA2187402C (en) 2000-08-08
ES2168119T3 (es) 2002-06-01
DE69619088D1 (de) 2002-03-21
DE69619088T2 (de) 2002-07-11
EP0784973B1 (en) 2002-02-06
JPH09132530A (ja) 1997-05-20
US5840723A (en) 1998-11-24
CA2187402A1 (en) 1997-04-11
EP0784973A2 (en) 1997-07-23

Similar Documents

Publication Publication Date Title
MY117896A (en) Quinazoline derivatives
DK0565549T3 (da) Anvendelse af 1,3-oxathiolannucleosidanaloger til fremstilling af et præparat til behandling af hepatitis B
SE9604786D0 (sv) New compounds
DK0863875T3 (da) Hidtil ukendte 4-(oxyalkoxyphenyl)-3-oxy-piperiner til behandling af hjerte- og nyrelidelser
DE69604714D1 (de) Stilbenderivate und diese enthaltende pharmazeutische Zusammensetzungen
ATE226574T1 (de) 4,6-diarylpyrimidin-derivate und deren salze
PT768086E (pt) Tratamento de tinido utilizando agentes neuroprotectores
DK132188D0 (da) Anvendelse af tetrahydrobenz(c,d)indol-6-carboxamider som anxiolytika
NZ308398A (en) 2-amino benzoxazin-4-one derivatives and medicaments
DE69828197D1 (de) Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut
DK0604186T3 (da) HIV-proteaseinhibitorer, som er egnede til behandling af AIDS
DK0784973T3 (da) Quinoxalinderivater til behandling af tinnitus
DK0617959T3 (da) Lægemiddel til behandling af hudsygdomme
DE69600231D1 (de) N-Arylalkylphenylacetamidderivate
SE9702716D0 (sv) Substituted phenylazacycloalkanes in the treatment of cognitive disorders
NO861868L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksatian-derivater.
DK0566288T3 (da) Flavon-derivater
MX9205408A (es) Metodo para tratar hipertension.
DK0578052T3 (da) Anvendelse af iminoderivater af etianaldehyd til fremstilling af et lægemiddel til behandling af hypertension
PT889044E (pt) Derivados do 5-(heteroaril)alquil-3-oxo-pirido-(1,2-a)benzimidazole-4-carboxamida (pbi) uteis no tratamento de perturbacoes do sistema nervoso central
ATE186912T1 (de) Carbamoylpyrrolidon-derivate zur behandlung von depressionen und cerebrovasculären störungen
DE3782229D1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
DE69722630D1 (de) Therapeutisches mittel zur behandlung von nierenerkrankungen
ATE81466T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur prophylaxe und zur behandlung von herzinsuffizienz.
EP0447812A3 (en) Use of a dihydropyridine to improve the inner ear blood circulation